| 000 | 03018nam a22004215i 4500 | ||
|---|---|---|---|
| 001 | 60591 | ||
| 005 | 20200226102628.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 161031s2017 si | s |||| 0|eng d | ||
| 020 |
_a9789811018787 _9978-981-10-1878-7 |
||
| 024 | 7 |
_a10.1007/978-981-10-1878-7 _2doi |
|
| 035 | _a(DE-He213)978-981-10-1878-7 | ||
| 050 | 4 | _aRD592.5-596 | |
| 072 | 7 |
_aMNN _2bicssc |
|
| 072 | 7 |
_aMED085010 _2bisacsh |
|
| 082 | 0 | 4 |
_a617.48 _223 |
| 245 | 1 | 0 |
_aTreatment of Non-vitamin K Antagonist Oral Anticoagulants _h[electronic resource] : _bFor Prevention of Stroke / _cedited by Masaaki Uno, Kuniaki Ogasawara. |
| 264 | 1 |
_aSingapore : _bSpringer Singapore : _bImprint: Springer, _c2017. |
|
| 300 |
_aIX, 99 p. 31 illus., 13 illus. in color. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 505 | 0 | _a1.Intracranial Bleeding -- 2.Severity and Outcomes of Intracerebral Bleeding and Cardiac Cerebral Embolism -- 3.Influence for Intracranial Bleeding Surgery -- 4.New Approaches for the Secondary Prevention of Cryptogenic Stroke Using Non-Vitamin K Antagonist Oral Anticoagulants -- 5.Secondary Prevention of Cerebral Infarct: Verification of Appropriateness in Choices of Anticoagulant by Comparison of Current and previous Treatment Results -- 6.Putaminal Hemorrhage in Patients with Oral Anticoagulants -Course of Treatment and Results of Endoscopic Evacuation -- 7.Secondary Prevention of Stroke with Atrial Fibrillation by New Oral Anticoagulants -- 8.Causes and Outcome in Patients with Cerebral Hemorrhage Using Anticoagulated Drugs. | |
| 520 | _aThis book describes new concepts and strategies for the clinical application of non-vitamin K antagonist oral anticoagulants (NOACs) for stroke. Although vitamin K antagonists have traditionally been used for the prevention of stroke, there are some problems associated with their use, such as the risk of intracranial hemorrhage, the need for dietary restrictions, and individual variability. Recently, NOACs have been introduced as alternatives to traditional anticoagulants and are becoming an option for treating stroke patients around the globe. However, their use is not without risk. Each chapter describes the successful use of NOACs for stroke patients and discusses their future impact from various points of view. The book is primarily written for neurosurgeons and neurologists but is also of interest to cardiologists involved in stroke treatment. | ||
| 650 | 0 | _aMedicine. | |
| 650 | 0 | _aNeurosurgery. | |
| 650 | 1 | 4 | _aMedicine & Public Health. |
| 650 | 2 | 4 | _aNeurosurgery. |
| 700 | 1 |
_aUno, Masaaki. _eeditor. |
|
| 700 | 1 |
_aOgasawara, Kuniaki. _eeditor. |
|
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer eBooks | |
| 776 | 0 | 8 |
_iPrinted edition: _z9789811018770 |
| 856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/978-981-10-1878-7 |
| 912 | _aZDB-2-SME | ||
| 999 |
_c8337 _d8337 |
||